Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9391)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jun 7, 2017 (publication date) through Nov 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Buanes TA. Role of surgery in pancreatic cancer. World J Gastroenterol 2017; 23(21): 3765-3770 [PMID: 28638216 DOI: 10.3748/wjg.v23.i21.3765] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v23/i21/3765.htm |
| Number | Citing Articles |
| 1 |
Nikhil Gupta, Raghav Yelamanchi. Pancreatic adenocarcinoma: A review of recent paradigms and advances in epidemiology, clinical diagnosis and management. World Journal of Gastroenterology 2021; 27(23): 3158-3181 doi: 10.3748/wjg.v27.i23.3158
|
| 2 |
Vineet K. Gupta, Sulagna Banerjee, Ashok K. Saluja. Clinical Pancreatology for Practising Gastroenterologists and Surgeons. 2021; : 564 doi: 10.1002/9781119570097.ch69
|
| 3 |
Pierre-Olivier Frappart, Thomas G. Hofmann. Pancreatic Ductal Adenocarcinoma (PDAC) Organoids: The Shining Light at the End of the Tunnel for Drug Response Prediction and Personalized Medicine. Cancers 2020; 12(10): 2750 doi: 10.3390/cancers12102750
|
| 4 |
Ashish Saharia, Lucy M. Potter, Flavio Baio, Ahmed Elaileh, Constance Mobley, Rafik M. Ghobrial, Maen Abdelrahim, Kirk Heyne. Is Surgery-first Still a Reasonable Option in the Era of Neoadjuvant Chemotherapy for Resectable Pancreatic Cancer?. American Journal of Clinical Oncology 2020; 43(4): 298 doi: 10.1097/COC.0000000000000661
|
| 5 |
Houda Abrini, Mounia Amzerin, Aicha El Baaboua, Sara Aboulaghras, Alia Bouhda, Fatima Zahra El Mrabet. Comparison of different Pancreatic cancer treatments: a three-year retrospective study in the oncology center of Tangier university hospital, Morocco. BMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-03071-0
|
| 6 |
Trond Buanes, Bjørn Edwin. Long term oncological outcome of laparoscopic techniques in pancreatic cancer. World Journal of Gastrointestinal Endoscopy 2018; 10(12): 383-391 doi: 10.4253/wjge.v10.i12.383
|
| 7 |
Bhuwan Giri, Anthony Ferrantella, Prateek Sharma, Tejeshwar Jain, Harrys K.C. Jacob, Shrey Modi, Saba Kurtom, Pooja Roy, Vrishketan Sethi, Sulagna Banerjee, Nipun Merchant, Sundaram Ramakrishnan, Ashok Saluja, Vikas Dudeja. An Immunocompetent Model of Pancreatic Cancer Resection and Recurrence. Journal of Gastrointestinal Surgery 2021; 25(5): 1271 doi: 10.1007/s11605-020-04681-9
|
| 8 |
Zhengshu Lu, Yanrui Ding. The m6A RNA methylation regulators related transcriptome for identification of pancreatic cancer subtypes and prognostic markers. 2021 4th International Conference on Algorithms, Computing and Artificial Intelligence 2021; : 1 doi: 10.1145/3508546.3508584
|
| 9 |
Laura Antolino, Paolo Aurello, Federico Todde, Silvia Amato, Niccolò Petrucciani, Andrea Kazemi Nava, Giuseppe Nigri, Stefano Valabrega, Giovanni Ramacciato, Francesco D’Angelo. Advances in Pancreatic Cancer. 2018; doi: 10.5772/intechopen.76750
|
| 10 |
Bart M.G. Baekelandt, Morten W. Fagerland, Marianne J. Hjermstad, Turid Heiberg, Knut J. Labori, Trond A. Buanes. Survival, Complications and Patient Reported Outcomes after Pancreatic Surgery. HPB 2019; 21(3): 275 doi: 10.1016/j.hpb.2018.07.023
|
| 11 |
Iranzu González-Borja, Antonio Viúdez, Saioa Goñi, Enrique Santamaria, Estefania Carrasco-García, Jairo Pérez-Sanz, Irene Hernández-García, Pablo Sala-Elarre, Virginia Arrazubi, Esther Oyaga-Iriarte, Ruth Zárate, Sara Arévalo, Onintza Sayar, Ruth Vera, Joaquin Fernández-Irigoyen. Omics Approaches in Pancreatic Adenocarcinoma. Cancers 2019; 11(8): 1052 doi: 10.3390/cancers11081052
|
| 12 |
Michał Piątek, Katarzyna Kuśnierz, Michał Bieńkowski, Rafał Pęksa, Marek Kowalczyk, Sergiusz Nawrocki. Primarily resectable pancreatic adenocarcinoma – to operate or to refer the patient to an oncologist?. Critical Reviews in Oncology/Hematology 2019; 135: 95 doi: 10.1016/j.critrevonc.2019.01.010
|
| 13 |
Jung Ae Kang, Jung Hyu Sin, Hye Lim Lee, Hye Rim Kim, Sung Hun Kim, Min-Kyoung Kang, A-Ram Yu, Min-Hee Son, Hye-Jin Park, Jae Jun Lee. Inhibition of Pancreatic Cancer Cell Viability and Tumor Growth Through Cell Cycle Arrest by an Oral Formulation of Docetaxel DHP23001. International Journal of Pharmacology 2019; 15(8): 994 doi: 10.3923/ijp.2019.994.1000
|
| 14 |
Jiali Wu, Zishan Xie, Chuqian Lei, Liwa Yu, Rui Huang, Ming Li, Lu Yuan, Weixing Zhang. Effect of surgery on the survival of elderly patients with early stage pancreatic cancer: A propensity‐matched analysis. Aging and Cancer 2022; 3(3-4): 169 doi: 10.1002/aac2.12057
|
| 15 |
Márton Benke, Nelli Farkas, Péter Hegyi, Benedek Tinusz, Patrícia Sarlós, Bálint Erőss, Kata Szemes, Nóra Vörhendi, Zsolt Szakács, Ákos Szücs. Preoperative Serum Carbohydrate Antigen 19-9 Levels Cannot Predict the Surgical Resectability of Pancreatic Cancer: A Meta-Analysis. Pathology and Oncology Research 2022; 28 doi: 10.3389/pore.2022.1610266
|
| 16 |
Jyun-Ming Huang, Sheng-Hsien Chen, Te-Hung Chen. Short-Term Outcomes of Conventional Laparoscopic versus Robot-Assisted Distal Pancreatectomy for Malignancy: Evidence from US National Inpatient Sample, 2005–2018. Cancers 2024; 16(5): 1003 doi: 10.3390/cancers16051003
|
| 17 |
Daniel C. Osei-Bordom, Gagandeep Sachdeva, Niki Christou. Liquid Biopsy as a Prognostic and Theranostic Tool for the Management of Pancreatic Ductal Adenocarcinoma. Frontiers in Medicine 2022; 8 doi: 10.3389/fmed.2021.788869
|
| 18 |
Yimamumaimaitijiang Abula, Yating Su, Dilixiati Tuniyazi, Chao Yi. Desmoglein 3 contributes to tumorigenicity of pancreatic ductal adenocarcinoma through activating Src–FAK signaling. Animal Cells and Systems 2021; 25(3): 195 doi: 10.1080/19768354.2021.1943707
|
| 19 |
Maciej Słodkowski, Marek Wroński, Dominika Karkocha, Leszek Kraj, Kaja Śmigielska, Aneta Jachnis. Current Approaches for the Curative-Intent Surgical Treatment of Pancreatic Ductal Adenocarcinoma. Cancers 2023; 15(9): 2584 doi: 10.3390/cancers15092584
|
| 20 |
Arthur Marichez, Olivier Turrini, Benjamin Fernandez, Jonathan Garnier, Bruno Lapuyade, Jacques Ewald, Jean-Philippe Adam, Ugo Marchese, Laurence Chiche, Jean-Robert Delpero, Christophe Laurent. Does pre-operative embolization of a replaced right hepatic artery before pancreaticoduodenectomy for pancreatic adenocarcinoma affect postoperative morbidity and R0 resection? A bi-centric French cohort study. HPB 2021; 23(11): 1683 doi: 10.1016/j.hpb.2021.04.003
|
| 21 |
Sultan Abdullah Alomari, Ahmed Sami Alfaqihi, Khalid Abdullah Alzahrani, Khalid Hassan Alzahrani, Khalid Mohammed Alzahrani, Khalid Abdulrahman Alzahrani, Abdulrahman Ahmed Asiri, Amjad Ali Durayb, Abdulaziz Marzouq Aloatibi, Mohammed Bassam Ghandourah. An Overview on the Role of Surgery in Resectable Pancreatic Tumors, Literature Review. Pharmacophore 2021; 12(4): 86 doi: 10.51847/RxWepx87LV
|
| 22 |
Malek Zihlif, Tareq Hameduh, Nailya Bulatova, Hana Hammad. Alteration in the expression of the chemotherapy resistance‑related genes in response to chronic and acute hypoxia in pancreatic cancer. Biomedical Reports 2023; 19(6) doi: 10.3892/br.2023.1670
|
| 23 |
Anna Gardiner, John Kidd, Maria C Elias, Kayla Young, Brent Mabey, Nassim Taherian, Shelly Cummings, Mokenge Malafa, Eric Rosenthal, Jennifer B Permuth. Pancreatic Ductal Carcinoma Risk Associated With Hereditary Cancer-Risk Genes. JNCI: Journal of the National Cancer Institute 2022; 114(7): 996 doi: 10.1093/jnci/djac069
|
| 24 |
Malvi Savani, Rachna T. Shroff. Decision-Making Regarding Perioperative Therapy in Individuals with Localized Pancreatic Adenocarcinoma. Hematology/Oncology Clinics of North America 2022; 36(5): 961 doi: 10.1016/j.hoc.2022.07.003
|
| 25 |
Yujun Gu, Yayun Ji, Hui Jiang, Ganbin Qiu. Clinical Effect of Driver Mutations of KRAS, CDKN2A/P16, TP53, and SMAD4 in Pancreatic Cancer: A Meta-Analysis. Genetic Testing and Molecular Biomarkers 2020; 24(12): 777 doi: 10.1089/gtmb.2020.0078
|
| 26 |
Mark Conor Harris, Georgi Atanasov, Eu Nice Neo, Andrew Goldfinch, Andrew Jin‐Hean Ng, Khimseng Tew, Lilian Kuan, Markus Trochsler, Harsh Kanhere. Value of the surgical pancreatic duct anatomy and associated outcomes in pancreatic cancer. ANZ Journal of Surgery 2024; 94(5): 894 doi: 10.1111/ans.18903
|